P300 and Genetic Risk for Schizophrenia
Georg Winterer(Charité - Universitätsmedizin Berlin), Daniel R. Weinberger(Johns Hopkins University), Carmen E. Sanchez(National Institutes of Health), Douglas W. Jones(University of Massachusetts Chan Medical School), Michael Egan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Thomas J. Raedler(National Institutes of Health), Richard Coppola(United States Department of Health and Human Services)
Cited by 112
Related Papers
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
|Brain|2009|962
Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts
|Psychophysiology|1993|687
Executive Subprocesses in Working Memory
|Archives of General Psychiatry|2003|585